Evidence map›Paper›PMID 33810416›Full record

ReviewMolecules (Basel, Switzerland)2021

Molecular Basis of the Therapeutical Potential of Clove (

Caterina Vicidomini, Valentina Roviello, Giovanni N Roviello

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 139 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Clove (Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Enhancing Dental Alginate withGels (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Article
  9. Therapeutic Potential ofCardiovascular & hematological agents in medicinal chemistry · 2024
    Article
  10. COVID-19 in Dental Practice Is Prevented by Eugenol Responsible for the Ambient Odor Specific to Dental Offices: Possibility and Speculation.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Multi-Targeting Neuroprotective Effects ofInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Potential Anti-SARS-CoV-2 Molecular Strategies.Molecules (Basel, Switzerland) · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Caterina VicidominiIstituto di Biostrutture e Bioimmagini IBB-CNR, Via Tommaso De Amicis 95, 80145 Naples, Italy.
Valentina RovielloDepartment of Chemical Materials and Industrial Production Engineering (DICMaPI), University of Naples Federico II, Piazzale V. Tecchio 80, 80125 Naples, Italy.ORCID 0000-0001-7340-8101
Giovanni N RovielloIstituto di Biostrutture e Bioimmagini IBB-CNR, Via Tommaso De Amicis 95, 80145 Naples, Italy.ORCID 0000-0001-6065-2367
Institute of Biostructure and Bioimaging · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current COronaVIrus Disease 19 (COVID-19) pandemic caused by SARS-CoV-2 infection is enormously affecting the worldwide health and economy. In the wait for an effective global immunization, the development of a specific therapeutic protocol to treat COVID-19 patients is clearly necessary as a short-term solution of the problem. Drug repurposing and herbal medicine represent two of the most explored strategies for an anti-COVID-19 drug discovery. Clove (

Indexed as

COVID-19COVID-19 Drug TreatmentAdjuvants, ImmunologicAnti-Inflammatory Agents, Non-SteroidalAntiviral AgentsFibrinolytic AgentsHerbal MedicineHumansPhytochemicalsPlants, MedicinalSyzygiumAdjuvants, ImmunologicAnti-Inflammatory Agents, Non-SteroidalAntiviral AgentsFibrinolytic AgentsPhytochemicalsclovecoronavirus infectionsCOVID-19eugeniineugenolherbal medicinenatural compoundspandemicsphytochemicalsSARS-CoV-2Syzygium aromaticum

Identifiers

PMID33810416
PMCPMC8036487
OpenAlexW3150352671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.